keepsmiling - you read my mind...
it wouldn've been great to read about a huge increase in Recell sales in the past quarter, but i guess we still wait... good old biotech stocks - takes time.
i'm hoping they've kept the quarterly cashflow release vague on purpose(about split between recell and breath-a-tech sales), to serve as not much other than than just a cashflow update without going into too much detail of what's coming up in the next quarter and beyond.
let's hope for a seperate announcement on progress in China soon, and more information on developments in those 'core European markets among key ReCell users and
clinical centres' - as they've mentioned in todays cashflow release.
i think we all know FDA approval is still a while away so nothing surprising in regards to that.
volume was good again today and it seems like there's some momentum in the right direction...
mixed thoughts at the moment but staying positive for now...
Hoops
this is rubbish, page-10
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.38 |
Change
0.010(0.42%) |
Mkt cap ! $162.0M | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.41 | $2.36 | $275.0K | 115.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20068 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.40 | 43 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |